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K. V. N. RAO, S. KAILASAM, N. K. MENON, & S. RADHAKRISHNA
This paper reports the gross and rapid condensation of isoniazid in a commercial black-
currant-flavoured syrup. In vitro studies showed that the condensation was due, at least
partly, to the glucose contained in the syrup, paper chromatography having demonstrated
the presence of D(+) -glucose isonicotinoyl hydrazone. Controlled studies in human
beings showed that the absorption of isoniazid from the preparation was considerably
impaired by this condensation.
It is concluded that sugars such as glucose, fructose, and sucrose—especially glucose—
should not be used in isoniazid syrup preparations, and it is suggested that sorbitol, a stable
non-carbonyl compound, might be a suitable substitute.
In paediatric practice, isoniazid is often adminis-
tered in the form of syrup. A commercial isoniazid
syrup with a palatable blackcurrant flavour was used
in a controlled study of the value of chemoprophy-
laxis in close family contacts, aged less than 5 years,
of infectious tuberculosis patients. On assay, the free
isoniazid content of the syrup was found to be con-
siderably less than that stated. Preliminary experi-
ments indicated that the deficit of isoniazid was
present in a bound form from which free isoniazid
could be liberated by treatment with dilute mineral
acids. The present paper describes these experiments
and others undertaken to examine the implications
of this finding.
MATERIALS AND METHODS
Syrup preparations
The isoniazid syrup investigated in this trial was
a commercial preparation with a stated isoniazid
content of 20 mg/ml and a pleasant blackcurrant
flavour. The placebo was the same syrup without
isoniazid. Both products were imported in 80-oz
(2 273-cm3) screw-capped, amber-coloured bottles.
The syrup and placebo were stored at room tempe-
rature (approximately 26°C). All the estimations
reported here were made at room temperature.
Estimation of free isoniazid in the syrup
Direct method. Isoniazid syrup was diluted (1 in
1 000) with distilled water and the resultant solution
diluted (1 in 2) with 0.2 N sulfuric acid. After varying
intervals (see page 627), a 3-ml aliquot of this acid
solution was treated with 0.3 ml of vanillin reagent
(2 % vanillin in 25 % ethanol), and the optical density
was determined at 380 nm (G. A. Ellard, personal
co munication) against the reagent blank within
2 minutes, using 1-cm light-path cells in a Unicam
SP 600 spectrophotometer. The isoniazid content
was then read from a calibration graph obtained with
standard solutions of isoniazid (1 to 10 µg/ml) in
0.1 N sulfuric acid.
Extraction method. The method of Eidus & Little
(1962) was used, with some modifications. In brief,
3 ml of a solution of the isoniazid syrup in distilled
water (1 in 2 000) were first mixed with 1 ml of
0.1 N sodium hydroxide and 3.2 g of powdered
ammonium sulfate in a 250-ml stoppered conical
flask; the contents were then shaken together with
30 l of a solvent mixture containing chloroform and
butan-1-ol (7: 3) for 30 minutes in a rotary shaker.
* From the Tuberculosis Chemotherapy Centre, Madras-
31, India. The Centre is under the joint auspices of the
Next, 20 ml of the solvent extract were shaken for
Indian Council of Medical Research, the Tamil Nadu15 minutes with 4 ml of 0.1 N sulfuric acid, and the
(Madras State) Government, and the World Health Organi-
zation in collaboration with the Medical Research Council
isoniazid content in a 3-ml aliquot of the acid extract
of Great Britain. This paper is also being published in thewas estimated within 30 minutes, as in the direct
Indian Journal of Medical Research. method. Apart from free isoniazid, 12-13 % of the
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theoretical isoniazid content of glucose isonicotinoyl
hydrazone is estimated by this method.
Estimation of total isoniazid in the syrup
For the estimation of the total isoniazid content-
that is, the free and bound forms together–1 ml of
the syrup was subjected to acid hydrolysis by treat-
ment with 5 ml of 4 N hydrochloric acid for 15 mi-
nutes; the acid was then neutralized by the addition
of 5 ml of 4 N sodium hydroxide and the solution was
made up to 250 ml in distilled water. A further
dilution (1 in 8) was made of the resultant solution
in distilled water, and the isoniazid content was esti-
mated by the extraction method.
Estimation of isoniazid and its metabolites in urine
Free isoniazid. Free isoniazid was estimated by
the extraction method from a sample of 3 ml of
urine diluted in distilled water (usually 1 in 10).
Isonicotinoyl hydrazones. The hydrazones present in
urine were converted to free isoniazid by acid hydro-
lysis-that is, by treating 1 ml of urine with 1 ml of
0.5 N hydrochloric acid for 2 hours. Next, 1 ml of
0.5 N sodium hydroxide was added, the solution made
up to 10 ml with distilled water, and the total iso-
niazid content determined by the extraction method.
From this, the free isoniazid content (estimated as
described above) was subtracted to obtain the hydra-
zone content as isoniazid equivalent.
Acetylisoniazid. Acetylisoniazid was estimated by
the method of Venkataraman et al. (1968) without
oxidation with potassium permanganate, after an
initial acid hydrolysis of the urine (as above) followed
by neutralization with alkali to eliminate interference
from the hydrazones.
Isonicotinic acid. Urine was diluted with distilled
water (1 in 25) and 1 ml of the diluted urine was
used for the estimation of isonicotinic acid by the
method of Nielsch (1958), which is also used for
estimating, as isonicotinic acid, 40–50% of the
isonicotinoyl glycine present in urine (Nielsch &
Giefer, 1959).
The amounts of acetylisoniazid and isonicotinic
acid present in the urine were expressed as the milli-
gram equivalent of isoniazid.
Estimation of isoniazid in serum
Isoniazid was extracted from serum using the me-
thod described on page 625, but using 2 ml of 0.1 N
sulfuric acid. For estimating serum isoniazid con-
centrations of 0.2 µg/ml or more, 0.5 ml of the acid
extract was treated with 0.05 ml of vanillin reagent
in 2-cm light-path microcells and the optical density
was determined at 380 nm.
For determining isoniazid concentrations of less
than 0.2 µg/ml, the fluorometric method of Scott &
Wright (1967) was used, with the following modifi-
cations of Kailasam, Prema & Gangadharam (Tuber-
culosis Chemotherapy Centre, unpublished data).
Thus, 1.5 ml of the acid extract, obtained as described
in the previous paragraph, was neutralized with
0.1 ml of 1.0 N sodium hydroxide and then treated
f r 15 minutes with 0.4 ml of salicylaldehyde reagent.
(This reagent was prepared just before use by
mixing 3 volumes of 0.1% salicylaldehyde in 1%
ethanol with 1 volume of 11.2 % acetic acid.) Next,
1.3 ml of a solution containing 0.385 M sodium
acetate, 0.154 % sodium disulfite (disodium pyro-
sulfite, Na2S2O5), and 0.1 N sodium hydroxide
were added, followed by 0.05 ml of 2-mercapto-
ethanol (the PH of the solution at this stage was
5.6). After having been treated at 50°C for 10 min-
utes, the solution was cooled to room temperature
and 3.5 ml of isobutyl alcohol and 2 g of powdered
ammonium sulfate were added.The contents
of the flask were thoroughly shaken by hand for
1 minute and then chilled in ice water. Finally, the
isobutyl alcohol layer was transferred to a dry test-
tube. While the extract was kept ice cold, its inten-
sity of fluorescence was measured within 10 minutes,
using a Beckman DU spectrophotometer with a
fluorescence attachment.1 Solutions of isoniazid in
concen rations of 0.01 to 0.16 µg/ml in serum were
us d for the calibration graph.
Identification of sugars and hydrazones in both syrups
by paper chromatography
Dilute solutions of the isoniazid and placebo syrups
in distilled water, and standard solutions in distilled
water of isoniazid, glucose, fructose, and D(+)- glu-
cose isonicotinoyl hydrazone, prepared by the method
of Fox (1953), were spotted qualitatively on a What-
man No. 1 filter paper; the paper was folded in the
form of a cylinder and kept upright in a solvent sys-
tem containing propan-2-ol and water (Zamboni &
Defranceschi, 1954). The chromatogram was develop-
ed for 16-18 hours. After drying, the paper was
exposed to cyanogen bromide vapours in a closed
chamber and was then sprayed with benzidine rea-
gent (0.5 g dissolved in a mixture of 20 ml of glacial
1 This attachment contains a Corning filter No. 5860
(ultraviolet), which transmits a band of wavelengths centr-
ing t 360 nm.
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D u r a t i o n  ( m i n )  o f  c o n t a c t  w i t h  a c i d
wHo 10675
Fig. 1. Effect of acid hydrolysis of isoniazid syrup (solid line) and D(+)-glucose isonicotinoyl hydrazone
(broken line)
acetic acid and 80 ml of absolute ethanol). Isoniazid(Fig. 1). These findings suggest that about 12 mg
and D(+)-glucose isonicotinoyl hydrazone producedof isoniazid per ml–i.e., about 60% of the stated
   yellow spots after exposure to cyanogen bromide,c ntent-were present in the syrup in a bound
whereas glucose and fructose gave brown spots afterf rm, being reconverted to free isoniazid after acid
spraying with benzidine reagent. hydrolysis.
INVESTIGATIONS AND RESULTS
Presence of isoniazid in bound form in the syrup
The free isoniazid content of each of 3 samples of
the isoniazid syrup was determined by the direct
method immediately (within 1 minute of making the
dilution with 0.2 N sulfuric acid), and thereafter at
intervals of 15 minutes for 3 hours. The mean free
isoniazid content of the 3 samples immediately after
making the dilution in acid was 8 mg/ml, as com-
pared with the stated content of 20 mg/ml.However,
it increased steadily to the stated content the longer
the isoniazid remained in contact with the acid
Fig. 1 also presents comparable data on the hydro-
lysis of D(+)-glucose isonicotinoyl hydrazone under
identical conditions. The similarity in the reaction
rates suggests that the bound form of isoniazid in
the yrup was probably D(+)-glucose isonicotinoyl
hyd azone.
The extraction method was employed to determine
the free isoniazid content of a further 15 samples
of th  syrup from a different batch. The mean con-
tent was 5.9 mg/ml (range: 5.2–6.6 mg/ml) before
acid hydrolysis and 20.6 mg/ml (range: 20.0–21.2 mg/
ml) after acid hydrolysis, confirming the observation,
made above, that a major proportion of the stated
content of isoniazid was present in a bound form.
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Sugar content of the placebo syrup
The placebo syrup contained, besides sucrose, 10 %
liquid glucose (approximately 40 % dextrin, 20 % malt-
ose, 20% glucose, and 20% water). Paper chroma-
tography revealed the presence of fructose, presum-
ably formed as a result of the break-down of sucrose.
Table 1.  Condensat ion of  isoniaz id
in d i f ferent  so lut ions
Solution
water (control)
Demonstration of isonicotinoyl hydrazone in the
isoniazid syrup 70 % sucrose
A dilute solution of the isoniazid syrup in distilled
water (1 in 250) yielded a positive result to the acetyl-
isoniazid test of Eidus & Hamilton (1964), presum-
ably owing to the presence of hydrazones. Whereas
paper chromatography revealed the presence of
D(+)-glucose and fructose (RF- values 0.88 and 0.91,
respectively) in the placebo syrup, the isoniazid syrup
was found to contain isoniazid and D(+)-glucose
isonicotinoyl hydrazone (RF values 0.97 and 0.93,
respectively) in addition to D( +)-glucose and fructose.
These findings suggest that the reduction in the free
isoniazid content was attributable, at least partly, to
condensation of the isoniazid with the glucose pre-
sent in the syrup.
5 % fructose
5 % glucose
Mixture of 60 % sucrose,
5 % fructose, and
5 % glucose
Blackcurrant-flavoured syrup
Condensation of isoniazid in different solutions
To study the extent and speed of condensation
of isoniazid in the blackcurrant-flavoured syrup and
its constituent reducing sugars, the following experi-
ment was undertaken. Isoniazid in a concentration
of 20 mg/ml was dissolved in (a) water (control),
(b) 70 % sucrose, (c) 5 % fructose, (d) 5 % glucose,
(e) a mixture of 60 % sucrose, 5 % fructose, and 5 %
glucose, and (f)the placebo syrup. All the solutions
were stored in screw-capped bottles at 26°C, and
their free isoniazid content was determined by the ex-
traction method (without acid hydrolysis) on the
second day (i.e., after 24 hours’ storage) and on the
tenth and thirtieth days. The findings are set out in
Table 1 .
with 20 mg/ml in all the other solutions-and had
decreased to 5.2 mg/ml by the thirtieth day. This
may be explained partly by the fact that the black-
currant-flavoured syrup, which contained 10 %
liquid glucose, was more acidic (pH 4.3) than the
other solutions and partly by the evidence from
Table 2 that the speed of condensation of isoniazid
with glucose was enhanced by decreasing the pH
of the solution to 4.1.
Implications of the condensation of isoniazid in syrup
The finding that a substantial proportion (about
60–70%) of the isoniazid in the syrup was present
in a bound form (page 627) does not necessarily imply
that the tuberculostatic potency of the preparation
was considerably impaired. Thus, it is possible that
some or all of the bound isoniazid was converted
into free isoniazid in the stomach by the action of
the gastric juice, and then absorbed. To investigate
this possibility, a study was undertaken in 6 healthy
No loss of free isoniazid occurred in water (con-
trol). A slight loss occurred in the 70% sucrose and
the 5 % fructose solutions, their free isoniazid content
on the thirtieth day being 18.4 mg/ml and 17.2 mg/ml,
respectively. Condensation was greater and more
rapid in the 5 % glucose solution and in the sucrose-
fructose-glucose mixture, the free isoniazid content
being 14.2 mg/ml on the tenth day and 7.6 mg/ml on
the thirtieth day for the former, and 11.4 mg/ml
and 6.8 mg/ml, respectively, for the latter. Finally,
condensation was greater and very rapid in the
blackcurrant-flavoured syrup, whose free isoniazid
content was 7.4 mg/ml on the second day-compared
T a b l e  2 .  I n f l u e n c e  o f  p H  o n  t h e  c o n d e n s a t i o n
of  ison iaz id  in  l iqu id  g lucose and g lucose so lut ions
Solution
10 % liquid glucose
5 % glucose
Free isoniazid content
2nd day 10th day
20.0
20.0
20.0
20.0
20.0
7.4
20.0 18.4
19.2 17.2
14.2 7.6
11.4
6.6
30th day
20.0
6.8
5.2               
6.3
4.1
8.7
8.9
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children, all aged about 5 years. Three of them, select-
ed at random, were given the isoniazid syrup in an
intended dose of 15 mg of isoniazid per kg of body
weight (based on the stated content of 20 mg/ml).
As a control, the other 3 children received the same
dose of isoniazid (15 mg/kg) in slightly sweetened
dilute milk containing isoniazid in a concentration
of 20 mg/ml (the isoniazid was added to the milk
just before the dose was given). From each child, all
the urine excreted during each of the 3 consecutive
2-hour periods immediately following medication
was collected., All the 18 samples (i.e., 3 from each
of the 6 children) were marked with code numbers
and sent to the laboratory, where their content of
    isoniazid and its metabolites was estimated. The ex-
periment was repeated a week later, isoniazid (in the
same dose) being given in milk to the children who
had received it in syrup on the first occasion, and
vice versa.
It was found that 15.4 % of the dose administered
in milk (control) was excreted in the urine as iso-
niazid or its metabolites during the first 2 hours,
compared with only 4.6% of the dose given in
the syrup. The corresponding proportions were
19.9% and 6.8%, respectively, during the second
2-hour period, and 13.5% and 4.5%, respectively,
during the third 2-hour period. Thus, during the first
6 hours, 48.8 % of the dose administered in milk was
excreted as isoniazid or its metabolites, compared
with only 15.9 % of the dose administered in the syrup,
the latter being 33% of the former. It is to be
noted that the free isoniazid content of the syrup
was 6.3 mg/ml–i.e., 32% of the stated content of
20 mg/ml. The pattern of urinary excretion–i.e.,
the composition of the total excretion as acetyliso-
   niazid, hydrazones, isonicotinic acid, and isoniazid-
was the same whether the isoniazid was administered
in milk or in syrup. Thus, the findings of the first
6 hours fail to provide any evidence that the bound
form was absorbed or converted to the free form in
the stomach or the gut.
It was observed that, even when the isoniazid
was given in milk, only 48.8% of the dose adminis-
tered was excreted in the first 6 hours. It was de-
cided, therefore, to study the amount excreted over
a longer period (24 hours) and to determine the
serum isoniazid concentrations attained after ad-
ministration of the drug in syrup and in milk.
For organizational convenience, the study was
undertaken in 4 healthy adults aged 26-32 years.
Each received a uniform dose of 600 mg of isoniazid
in 30 ml of milk on one occasion and, on another
occasion, as 30 ml of the syrup investigated.The otal
urine excreted during the 24 hours after administra-
tion of the drug (i.e., during the consecutive periods
0–6, 6–10, and 10–24 hours) was collected, blood
samples being taken 1½ and 10 hours after medication.
Th  procedures used were the same as for the study
in children, and the findings are set out in Table 3.
With regard to the total excretion of isoniazid and
its metabolites, 50.9% of the dose administered in
milk was excreted during the first 6 hours, compared
with only 22.9% of that given in the syrup. Over
the whole 24-hour period, 82.4% of the dose ad-
ministered in milk was excreted, compared with
46.8% of that given in the syrup, the latter being
57 % of the former.
The mean serum isoniazid concentrations were
10.9 µg/ml 1½ hours following the administration
f iso iazid in milk and 3.1 µg/ml after it was given
in syrup; the corresponding values at 10 hours were
0.8 µg/ml and 0.5 µg/ml.
In summary, there is strong evidence that sub-
stantially less isoniazid was absorbed from the syrup
than from the milk (control).
Absorption of isoniazid from the bound form in the
syrup
The free isoniazid content of the syrup used for
the study in adults was 6.5 mg/ml–i.e., 32.5 % of the
stated content of 20 mg/ml (the remaining 67.5%
being resent in the bound form). Therefore it might
be expected that the total excretion of isoniazid and
its metabolites after the drug was given in syrup
would be 32.5 % of that following its administration
i  milk, unless there were a contribution from the
bound form in the syrup. During a 24-hour period,
the observed proportion was appreciably higher–
i.e., 57% (Table 3, last column), indicating that
absorption from the bound form had occurred to
some extent. Further calculations (not presented
here) showed that about 9% of the bound form was
excreted as isoniazid or its metabolites in the first
6 hours, 7 % in the next 4 hours, and 13 % in the
next 14 hours–i.e.,a total of 29% in the first
24 hours. A further investigation, in which 3 of the
4 adults studied earlier again received 30 ml of the
isoniazid syrup, showed that less than 8% of the
bound form was excreted during the second 24-hour
period after medication. All 3 patients had serum
isoniazid concentrations of <0.2 µg/ml 24 hours after
taking the drug. The rate of excretion from the
bound form was 1.5 % per hour during the first
6 hou s; 1.8% per hour during the next 4 hours;
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Table 3.  Excret ion of  isoniaz id  and i ts  metabol i tes  in  ur ine dur ing the 24 hours  fo l lowing administ rat ion
of  the drug in  mi lk  (contro l )  and in  syrup
Excretion in urine as percentage of administered dose of isoniazida
Compound
I
0-6 hours 6-10 hours         10-24 hours        O-24 hours
Milk
Acetylisoniazid
Hydrazones
Isonicotinic acid
lsoniazid
Total
20.5
3.6
8.1
18.7
50.9
Syrup Milk
10.6 10.0
1.8 1.5
4.8 4.5
5.7 3.5
22.9 19.5
a Mean of the results for 4 adults.
1.9 1.4 1.3 23.6 8.9 38
1 1 . 3  12.0  12.6  82.4  46.8  5 7
0.9% per hour during the 14 hours after that; and
<0.3% per hour in the subsequent 24-hour period.
The decreasing trend suggests that little excretion
is likely to occur 48 or more hours after medication.
It may be concluded, therefore, that about 37% of
the isoniazid present in bound form in the syrup
could have been converted into free isoniazid in the
body.
DISCUSSION
Isoniazid is known to be incompatible with
aldehydes and ketones (Todd, 1967) owing to
condensation of these compounds with isoniazid.
Sugars such as glucose and fructose, containing
aldehyde or ketone groups, are also known to form
condensation products with isoniazid. Nevertheless,
there has been no report so far about the conden-
sation of isoniazid in syrup preparations of the kind
often used in paediatric practice. The commercial
isoniazid syrup investigated was found to have
a free isoniazid content of 6-8 mg/ml, as against
the stated content of 20 mg/ml, the deficit being
present in a bound form from which free isoniazid
could be liberated by acid hydrolysis. In vitro
studies showed that substantial condensation of
isoniazid occurred within 24 hours, and paper chro-
matography demonstrated the presence of D(+)-
glucose isonicotinoyl hydrazone, indicating that the
condensation was due, at least in part, to the glucose
in the syrup.
Peters & Hayes (1966) studied the metabolism
of glucose isonicotinoyl hydrazone in dogs after
int ave ous injection, and discovered that less than
30% of the hydrazone was converted to isoniazid
in the body. Kakemi et al. (1965) found poor
absor tion of the glucose derivative of isoniazid
in their studies of urinary excretion in man. These
findings suggest that a considerable proportion of
the glucose isonicotinoyl hydrazone in the isoniazid
syrup might not have been available as isoniazid.
Controlled studies in human subjects at this Centre
showed that absorption from the bound form was
rather slight (37 %). Furthermore, the evidence that
the relative excretion of hydrazones in the urine was
not si nificantly elevated (Table 3) suggests that
the bound form that had been absorbed was pro-
bably broken down to isoniazid in the stomach or
gut. Thus, the amount of free isoniazid available
must have been less than 60% of the stated content
(32.5 % + 37 % x 67.5 %, suggesting that the potency
of the isoniazid syrup studied at this Centre may
have been impaired by the condensation of iso-
niazid.
These findings suggest that syrup preparations
of isoniazid should be assayed periodically and
that the methods employed should be specific for
the determination of free isoniazid.
Manufacturers would be well advised to avoid
the inclusion of sugars such as glucose, fructose,
and sucrose in syrup preparations of isoniazid.
Sorbitol, a stable non-carbonyl compound, may
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Table 4.  Ef fect  of  storage at  26°C on the f ree isoniaz id
content  of  a  syrup preparat ion of  isoniaz id in  sorb i to l
Duration No. of
of storage samples
(months) tested
Free isoniazid content
(mg/ml)
Mean Range
None a 6 32.2 31.2-33.6
8 31.2 29.7-34.6
7 31.5 30.0-34.6
7 32.3 30.0-33.6
7 32.2 30.0-33.2
7 31.1 30.0-32.3
7 29.8 28.8-30.6
7 29.7 28.8-30.6
7 29.8 29.4-30.6
7 26.5 25.2-28.6
a Tested immediately on receipt.
be a suitable substitute; however, when adminis-
tered in high dosage, it is known to produce diar-
rhoea (Peters & Lock, 1958; Goodman & Gilman,
1965). At this Centre, the incidence of diarrhoea
over a 3-month period was 20% (unpublished data)
when a syrup preparation of isoniazid (10 mg/ml)
in sorbitol was administered twice weekly to 230
children aged less than 5 years (average dose of
sorbitol: 13.6 g), and in 8 cases the syrup had to be
discontinued for this reason. However, at a later
stage, when another isoniazid syrup (30 mg/ml) in
sorbitol (average dose of sorbitol: 4.2 g) was admi-
nistered to 130 children for 1 year, diarrhoea was not
a problem. Furthermore, when the latter prepara-
tion was stored at 26ºC, it showed no loss of free
isoniazid in the first 6 months, and only a slight loss
(7%) during the subsequent 12 months (Table 4).
It may be concluded, therefore, that sorbitol is a
suitable vehicle for syrup preparations of isoniazid,
provided that the quantity of syrup administered is
small.
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